Reported Reactions

Adverse event reports that FDA received

  • Search
  • Watch list

March 2012 adverse event reports that FDA received in the month

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on . The data have the reports that FDA received through .

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.

Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on .

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports received

In March 2012, FDA received 55,316 drug adverse event reports. In March 2011, FDA received 41,538.

In March 2012, FDA received 36,604 medical device reports. In March 2011, FDA received 34,130.

By drug reports received, March 2012 was number 7 of the 12 months of 2012. FDA received 49,411 drug reports a month on average in the 12 months before March 2012.

Receive date

A month is the month in which FDA first received the report, not the month of the event. A report about an event of an earlier year is in the month in which it came to FDA.

Data version

FAERS release of 29 Oct 2026. MAUDE release of 23 Oct 2026.

Drug reports, three years

Drug reports that FDA received each month, 36 months to March 2012
050,000100,000201020112012

Drugs in the reports

The table has the 134 drug pages with 100 or more reports in March 2012. The rows are in order of name. A drug page with fewer reports is not in the table.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Drugs that the reports of March 2012 name as a suspect product, in order of name
DrugReports in the month
Accutane236
Acetaminophen320
Acetaminophen and Hydrocodone Bitartrate111
Actos110
Afinitor500
Alendronate sodium132
Aleve766
Alprazolam138
Aspirin284
Avandamet109
Avandia556
Avastin234
Avonex518
Betaseron138
Boniva169
Carbamazepine100
Carboplatin176
Celebrex252
Chantix825
Cisplatin170
Citalopram hydrobromide132
Clozaril182
Crestor335
Cyclophosphamide361
Cyclosporine124
Cymbalta164
Cytarabine165
Depakote144
Desvenlafaxine succinate160
Dexamethasone203
Dianeal606
Digoxin105
Diovan151
Diovan HCT101
Docetaxel139
Doxorubicin hydrochloride207
Drospirenone and ethinyl estradiol227
Duragesic-100118
Effexor136
Emsam118
Enbrel587
Erbitux656
Erlotinib hydrochloride106
Estradiol154
Exelon356
Exjade144
Extavia174
Extraneal144
Fanapt334
Fentanyl-100470
Fluorouracil166
Forteo525
Fosamax503
Gabapentin124
Gilenya1,392
Gleevec1,081
Humira712
Ibuprofen221
Incivek138
Invega Sustenna100
Lamictal125
Lamotrigine161
Lantus182
Lenalidomide268
Letairis230
Lipitor550
Lisinopril130
Lucentis117
Lupron Depot225
Lyrica624
Mabthera156
Metformin hcl212
Methotrexate253
Metoprolol succinate121
Mirena865
Mycophenolate mofetil160
Neurontin167
Nexium344
Nicorette735
Nicotine polacrilex225
Norvasc114
Nplate174
Omeprazole115
Paclitaxel137
Pegasys125
Plan B One-Step513
Plavix122
Pradaxa781
Prednisolone190
Prednisone336
Premarin100
Prograf175
Prolia502
Propacet 100290
Propoxyphene Hcl290
Propoxyphene Napsylate W/Acetaminophen295
Rebif364
Reclast105
Remicade822
Revlimid5,648
Ribavirin154
Risperdal118
Risperidone115
Rituximab135
Saphris229
Seroquel247
Sertraline hydrochloride139
Simvastatin142
Stelara107
Sutent226
Symbicort101
Tacrolimus119
Tasigna339
Tekturna185
Temazepam160
Tiotropium bromide320
Toprol-Xl550
Tracleer335
Tysabri1,807
Tyvaso355
Velcade186
Viagra206
Vincristine111
Warfarin sodium154
Xalatan108
Xarelto200
Xeloda214
Xgeva125
Yasmin663
Yaz800
Zoledronoc Acid300
Zoloft136
Zometa215
Zomig222

Reaction terms in the reports

The table has the 143 reaction terms with 250 or more reports in March 2012. The rows are in order of name. One report can record more than one term.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.

Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of . The site read the page on .

Reaction terms that the drug reports of March 2012 record, in order of name
Reaction term (MedDRA) and plain meaningReports in the month
Abdominal discomfortstomach discomfort449
Abdominal distensiona bloated abdomen279
Abdominal painstomach or belly pain826
Abdominal pain upperupper stomach pain596
Alopeciahair loss294
Amnesiamemory loss268
Anaemialow red blood cells913
Anxietyanxiety1,334
Arrhythmia454
Arthralgiajoint pain929
Astheniaweakness or lack of energy1,255
Atrial fibrillationan irregular heart rhythm445
Back painback pain887
Balance disorderproblems with balance290
Blood glucose increasedraised blood sugar reading340
Blood pressure decreaseda low blood pressure reading263
Blood pressure increaseda raised blood pressure reading461
Bronchitischest infection327
Cardiac arrestthe heart stopped347
Cardiac disorder653
Cardiac failureheart failure287
Cardiac failure congestivecongestive heart failure602
Cardio-respiratory arrestthe heart and breathing stopped476
Cardiovascular disorder448
Cerebrovascular accidentstroke765
Chest discomfortchest discomfort320
Chest painchest pain826
Chillschills or shivering388
Cholecystitis chronic257
Cholelithiasisgallstones265
Chronic obstructive pulmonary diseaseCOPD, a long-term lung disease281
Completed suicidedeath by suicide323
Condition aggravatedthe condition being treated got worse370
Confusional stateconfusion524
Constipationconstipation571
Contusiona bruise288
Convulsion549
Coughcough622
Deaththe patient died; cause not stated by this term2,282
Decreased appetitereduced appetite634
Deep vein thrombosisa blood clot in a deep vein755
Dehydrationdehydration594
Depressionlow mood1,056
Device expulsionthe device came out412
Diarrhoealoose or frequent stools1,651
Disease progressionthe disease advanced357
Dizzinesslight-headedness or unsteadiness1,528
Drug administration errora mistake in giving the medicine309
Drug dose omissiona dose was missed505
Drug hypersensitivityan allergic-type reaction (the term names a medicine)359
Drug ineffectivethe medicine did not work as expected2,095
Drug interactionan interaction between medicines516
Dyspepsiaindigestion347
Dysphagiadifficulty swallowing270
Dyspnoeashortness of breath1,992
Emotional distressemotional distress613
Erythemaskin redness380
Falla fall1,233
Fatiguetiredness2,182
Feeling abnormalfeeling odd or not right736
Femur fracture547
Foetal exposure during pregnancythe unborn baby was exposed to the medicine290
Full blood count decreased279
Gait disturbancedifficulty walking653
Gallbladder disorder265
Gastrointestinal haemorrhagebleeding in the stomach or bowel340
Gastrooesophageal reflux diseaseacid reflux321
General physical health deteriorationgeneral decline in health477
Haemoglobin decreasedlow haemoglobin496
Haemorrhagebleeding326
Hallucinationseeing or hearing things that are not there262
Headachehead pain1,701
Heart rate increaseda fast heart rate reading327
Hyperhidrosisexcessive sweating380
Hypersensitivityan allergic-type reaction540
Hypertensionhigh blood pressure779
Hypoaesthesianumbness607
Hypotensionlow blood pressure612
Infectionan infection, type not specified403
Influenzaflu263
Influenza like illnessflu-like symptoms338
Injurya physical injury633
Insomniadifficulty sleeping794
Intentional drug misuse409
Loss of consciousnesspassing out441
Malaisegeneral feeling of being unwell1,383
Maternal exposure during pregnancythe mother took the medicine during pregnancy314
Memory impairmentmemory problems395
Menstruation irregularirregular periods330
Migrainemigraine368
Multiple sclerosis relapsea flare of multiple sclerosis364
Muscle spasmsmuscle cramps639
Muscular weaknessmuscle weakness425
Myalgiamuscle pain513
Myocardial infarctionheart attack1,116
Nasopharyngitisa cold418
Nauseafeeling sick2,164
Neoplasm malignanta cancer, type not specified475
Neuropathy peripheralnerve damage in hands or feet302
Neutropenialow neutrophils, a type of white blood cell516
Nicotine dependence267
No adverse eventno adverse event was reported431
Oedema peripheralswelling of the legs, ankles or hands934
Off label useused for a purpose or in a way not on the label436
Oropharyngeal painsore throat254
Overdosea dose above the recommended amount344
Painpain, site not specified2,311
Pain in extremitypain in an arm or leg1,006
Palpitationsawareness of the heartbeat459
Pancytopenialow counts of all blood cells447
Paraesthesiatingling or pins and needles456
Platelet count decreasedlow platelet count611
Pleural effusionfluid around the lung297
Pneumonialung infection1,621
Product quality issuea problem with the product itself426
Pruritusitching725
Pulmonary embolisma blood clot in the lung828
Pyrexiafever1,163
Rashskin rash1,198
Renal failurekidney failure577
Renal failure acute488
Respiratory failurethe lungs could not supply enough oxygen257
Sepsisa severe body-wide response to infection407
Sinusitissinus infection281
Somnolencedrowsiness574
Stressstress272
Suicidal ideationthoughts of suicide328
Swelling facea swollen face260
Syncopefainting380
Tachycardiafast heart rate308
Thrombocytopenialow platelets468
Thrombosis608
Toxicity to various agentspoisoning or toxic effect of one or more substances328
Tremorshaking558
Urinary tract infectionbladder or urinary infection536
Urticariahives428
Vision blurredblurred vision374
Visual impairmentreduced vision327
Vomitingbeing sick1,467
Weight decreasedweight loss680
Weight increasedweight gain546
White blood cell count decreasedlow white cell count540
Wrong technique in drug usage processthe medicine was used in the wrong way257

Devices in the reports

The table has the 42 device pages with 100 or more reports in March 2012. The rows are in order of name. A device page with fewer reports is not in the table.

FDA says:

MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices.

Source: openFDA, Manufacturer and User Facility Device Experience. The site read the page on .

Device brand names that the device reports of March 2012 name, in order of name
Brand nameReports in the month
Access218
Access 2 Immunoassay System126
Accu-Chek Aviva Test Strips131
Accu-Chek Multiclix106
Accu-Chek Spirit109
Animas Insulin Infusion Pump297
Bravo318
Curlin Administration Set407
Durata Sts Optim Active Fixation Df-4 Connector146
Eon Mini IPG, 16-Channel Rechargeable190
Flogard449
Homechoice548
HomeChoice Automated PD Set with Cassette1,040
Homechoice Pro362
Infuso R100
Infusor192
LifeVest WCD 4000 System242
M Series147
Nucleus 24 Channel Cochlear Implant System218
Octrode Lead Kit, 60cm Length126
Onetouchping Glucosemgmtsystem625
Ot Ping Meter436
Ot Ultralink Meter394
Ot Verio Iq Meter118
Ot Verio Meter173
Ot Verio Pro Meter266
Paradigm Real-Time Insulin Infusion Pump521
Paradigm Real-Time Revel Insulin Infusion Pump192
Perclose Proglide 6f Suture Mediated Closure Smc System230
Precision?220
Restore Ultra112
Riata Active Fixation337
Secure 3 Med/Surg Bed109
Tendril Sdx129
Tendril St100
Totalcare152
Trilogy 100109
Unicel Dxi 800 Access Immunoassay System115
Unknown Depuy Asr Cup111
Unknown Depuy Asr Head154
Versacare Bed100
Xience V Everolimus Eluting Coronary Stent System104

Cite this page

Reported Reactions. March 2012: adverse event reports received by FDA. https://reportedreactions.com/month/2012-03/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of . Reports received through .

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The device counts come from the openFDA Device Adverse Event (MAUDE) bulk files, release of 23 Oct 2026. The files have the reports that FDA received through 30 Sep 2026. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

Can the count for March 2012 change?

Yes. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases. This page has the count of the openFDA release of 29 Oct 2026: 55,316 drug reports.

Does a month with many reports mean that something occurred in that month?

Not by itself. The date is the date on which FDA received the report, not the date of the event. FDA says:

Many factors can influence whether or not an event will be reported, such as the time a product has been marketed and publicity about an event.

Source: openFDA, Drug Adverse Event Overview. The site read the page on .

How does a person report an adverse event?

FDA runs MedWatch, a program that takes voluntary reports from health professionals, patients and consumers. The guide on how to report has the links.